Mizuho Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Mizuho Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$157K	Sell	1,699 -577	-25%	-$54.3K	0.03%	336
2016 Q2	$177K	Buy	2,276 +1,199	+111%	+$102K	0.03%	376
2016 Q1	$134K	Sell	1,077 -790	-42%	-$64.3K	0.04%	293
2015 Q4	$196K	Buy	1,867 +161	+9%	+$16.8K	0.04%	324
2015 Q3	$180K	Buy	1,706 +210	+14%	+$28.1K	0.04%	297
2015 Q2	$205K	Buy	1,496 +419	+39%	+$51.9K	0.05%	258
2015 Q1	$134K	Buy	1,077 +485	+82%	+$51.4K	0.04%	293
2014 Q4	$54K	Hold	592	–	–	0.02%	414
2014 Q3	$43K	Buy	592 +307	+108%	+$20.2K	0.01%	396
2014 Q2	$18K	Hold	285	–	–	﹤0.01%	593
2014 Q1	$19K	Hold	285	–	–	﹤0.01%	530
2013 Q4	$20K	Hold	285	–	–	﹤0.01%	488
2013 Q3	$21K	Buy	+285	New	+$18.9K	﹤0.01%	493

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mizuho Asset Management's BMRN Position: Q3 2016 in Review

Mizuho Asset Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 25% in Q3 2016, selling an estimated $54.3K and leaving 1,699 shares worth $157K. The position accounts for 0.03% of the portfolio, ranked #336.

Mizuho Asset Management first reported a position in BMRN in Q3 2013 and has held it in 13 quarters since. The position peaked at $205K in Q2 2015. 423 funds tracked by Wall St. Rank hold BMRN as of Q3 2016.

Mizuho Asset Management held 1,699 shares of BioMarin Pharmaceuticals worth $157K as of Q3 2016.
Mizuho Asset Management sold 577 BioMarin Pharmaceuticals shares in Q3 2016, an estimated $54.3K.
BioMarin Pharmaceuticals made up 0.03% of Mizuho Asset Management's portfolio in Q3 2016, its #336 holding.
Mizuho Asset Management first reported a position in BioMarin Pharmaceuticals in Q3 2013 and has held it in 13 quarters since.
Mizuho Asset Management's BioMarin Pharmaceuticals position peaked at $205K in Q2 2015.
423 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.